Table 1.
Clinicopathological characteristics of all ARDS’ patients.
| Variable | Mean (SD) or N (%) |
|---|---|
| Age, year | 70.7 (15.6) |
| Sex, male | 6,289 (61.8) |
| Annual Income level at ARDS treatment | |
| Q1 (lowest) | 2,870 (28.2) |
| Q2 | 1,527 (15.0) |
| Q3 | 2,022 (19.9) |
| Q4 (Highest) | 3,610 (35.5) |
| Unknown | 144 (1.4) |
| Treatment result | |
| Discharge, and follow up in same hospital | 2,732 (26.9) |
| Transfer to other long-term facility center | 627 (6.2) |
| Discharge, and outpatient clinic follow up | 2,680 (26.3) |
| Death within hospitalization | 4,134 (40.6) |
| Admitting department | |
| IM | 8,158 (80.2) |
| Non-IM | 2,015 (19.8) |
| Length of hospitalization, day | |
| Total cost for hospitalization, USD | 11,585.2 (14,234.2) |
| Cost per day, USD | 827.0 (908.7) |
| Hospital admission | |
| Transfer from other hospital | 440 (4.3) |
| Admission through Emergency Room | 6,279 (61.7) |
| Admission through outpatient clinic | 3,454 (34.0) |
| Annual case volume of ARDS admission | |
| Q1 ≤ 4 | 1,896 (18.6) |
| Q2: 5–14 | 2,429 (23.9) |
| Q3: 15–28 | 3,002 (29.5) |
| Q4 ≥ 29 | 2,846 (28.0) |
| Main diagnosis of ARDS | 5,127 (50.4) |
| Sepsis associated ARDS | 1,490 (14.6) |
| Diagnosis of shock during hospitalization | 901 (8.9) |
| CCI at hospital admission for ARDS | 4.7 (3.1) |
| ECMO support | 740 (7.3) |
| Duration of ECMO support, day | 1.6 (2.8) |
| NMB use | 3,789 (37.2) |
| CRRT use | 1,070 (10.5) |
| Duration of CRRT use, day | 3.3 (5.6) |
| Duration of Mechanical Ventilator support, day | 5.2 (8.3) |
| Experience of CPR during hospitalization | 1,160 (11.4) |
| 30-day mortality | 4,846 (47.6%) |
| 90-day mortality | 6,276 (61.7%) |
| 365-day mortality | 7,051 (69.3%) |
| Year of admission for ARDS | |
| 2014 | 1,707 (16.8) |
| 2015 | 1,608 (15.8) |
| 2016 | 1,869 (18.4) |
| 2017 | 1,706 (16.8) |
| 2018 | 1,713 (16.8) |
| 2019 | 1,570 (15.4) |
ARDS, acute respiratory distress syndrome; SD, standard deviation; IM, internal medicine; USD, United States Dollars; ECMO, extracorporeal membrane oxygenation; NMB, neuromusclar blockade; CRRT, continuous renal replacement therapy, CPR, cardiopulmonary resuscitation.